Status:
COMPLETED
Ambulatory Blood Pressure Monitoring for Antihypertensive Treatment Guidance
Lead Sponsor:
University Hospital, Basel, Switzerland
Collaborating Sponsors:
Bayer
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine whether in patients with arterial hypertension, treatment guidance using 24-hour blood pressure measurement results in better blood pressure control compared ...
Detailed Description
Blood pressure control in arterial hypertension remains poor, despite the availability of effective drug treatment. Therefore, strategies to increase blood pressure control are urgently needed. 24 hou...
Eligibility Criteria
Inclusion
- Uncontrolled hypertension (office BP \>139/89mmHg AND 24h BP \>129/79mmHg)
Exclusion
- Severe concomitant illness including heart failure, significant valvular heart disease or malignancy
Key Trial Info
Start Date :
October 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2007
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT00139984
Start Date
October 1 2003
End Date
May 1 2007
Last Update
February 2 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Outpatient Clinic, University Hospital Basel
Basel, Switzerland, 4031
2
Private Practice
Basel, Switzerland, 4057